Joseph M. Piepmeier

Medicine · Health Sciences

35h-index6.6kcitations143works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(65), Meningioma and schwannoma management(13), Neuroblastoma Research and Treatments(11), Spinal Cord Injury Research(9), Brain Metastases and Treatment(9)

Publications140 total

Imaging metabolism of deuterated glucose in patients with primary brain tumors
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
NEIM-11 DEUTERIUM METABOLIC IMAGING (DMI) DETECTS A LARGER WARBURG EFFECT IN HIGH-GRADE BRAIN TUMORS AND IN IDH WILD TYPE GLIOMAS
Neuro-Oncology Advances·2023· 1 citedOpen Access
NIMG-105. DEUTERIUM METABOLIC IMAGING (DMI) DETECTS A LARGER WARBURG EFFECT IN HIGH-GRADE BRAIN TUMORS AND IN IDH WILD TYPE GLIOMAS
Neuro-Oncology·2022Open Access
Leptomeningeal dissemination of low-grade neuroepithelial CNS tumors in adults: a 15-year experience
Neuro-Oncology Practice·2019· 6 citedOpen Access
SURG-03. A COMPARISON OF SURVIVAL OUTCOMES AFTER BIOPSY VERSUS RESECTION IN PRIMARY CNS LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE
Neuro-Oncology·2018Open Access
Mibefradil dihydrochoride with hypofractionated radiation for recurrent glioblastoma: A phase I dose expansion trial.
Journal of Clinical Oncology·2018· 11 cited
Leptomeningeal dissemination from low-grade neuroepithelial CNS tumors in adults: a 15-year experience (P6.159)
Neurology·2018
Malignant Brain Tumors
2016· 12 cited
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
Nature Genetics·2016· 338 citedOpen Access
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
DSpace@MIT (Massachusetts Institute of Technology)·2016· 6 citedOpen Access
Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging
ACS Nano·2016· 119 citedOpen Access
ATNT-15MIBEFRADIL DIHYDROCHORIDE WITH HYPOFRACTIONATED RADIATION FOR RECURRENT GLIOBLASTOMA: PRELIMINARY RESULTS OF A PHASE I DOSE EXPANSION TRIAL
Neuro-Oncology·2015Open Access
Brain Tumors: Practical Guide To Diagnosis And Treatment
2015· 9 cited
Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance
Journal of Neuro-Oncology·2014· 62 citedOpen Access
Abstract A86: Preclinical refinement of a highly-penetrative polymeric nanoparticle drug delivery system for the treatment of glioblastoma multiforme.
Molecular Cancer Therapeutics·2013
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
Proceedings of the National Academy of Sciences·2013· 265 citedOpen Access
Genomic Analysis of Non- <i>NF2</i> Meningiomas Reveals Mutations in <i>TRAF7</i> , <i>KLF4</i> , <i>AKT1</i> , and <i>SMO</i>
Science·2013· 852 citedOpen Access
Clinical Presentation in Diffuse Low-Grade Gliomas
2013· 1 cited
LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY
Neuro-Oncology·2012· 1 citedOpen Access
Abstract A21: High-throughput small molecule screening of genetically diverse glioblastoma stem cells
Cancer Research·2012
page 1 of 7Next →

Frequent Co-authors

W. Mark Saltzman(6), Joachim M. Baehring(5), Toral Patel(5), Jiangbing Zhou(5), Jennifer Moliterno Günel(3), William F. Collins(3), Franklin C. Wagner(3), Wise Young(3), Mitchel S. Berger(3), Anita Hüttner(3), Daizo Yoshida(3), Victoria Clark(2), E. Zeynep Erson‐Omay(2), Koray Özduman(2), Octavian Henegariu(2), Geneive Carrión-Grant(2), Hanwen Bai(2), Ketu Mishra-Gorur(2), Kaya Bilgüvar(2), Philip H. Gutin(2)